Long-Term Mortality and Morbidity Related to Congestive Heart Failure with Reduced Ejection Fraction (CHFrEF) in Palestinian Patients Maintained on Submaximal Sacubitril/Valsartan Doses: A Pilot Study

BACKGROUND: The efficacy of sacubitril/valsartan, a newly introduced combination drug for heart failure with reduced ejection fraction (HFrEF), was demonstrated in the PARADIGM-HF trial conducted in Western countries. However, these findings need to be verified in the Middle Eastern context, where p...

Descripción completa

Detalles Bibliográficos
Autores principales: Aqel, Raed, Alzughayyar, Tareq Z., Abukhalaf, Sadi A., Misk, Rami A., Zalloum, Jihad Samer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727118/
https://www.ncbi.nlm.nih.gov/pubmed/35027945
http://dx.doi.org/10.1155/2021/1829873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727118/
https://www.ncbi.nlm.nih.gov/pubmed/35027945
http://dx.doi.org/10.1155/2021/1829873

Ejemplares similares